Perspective Therapeutics to Participate in Upcoming Investor Conferences in December

Core Insights - Perspective Therapeutics, Inc. is a radiopharmaceutical company focused on advanced cancer treatment applications [3] - The company utilizes proprietary technology with the alpha-emitting isotope 212Pb to target cancer cells specifically [3] - The company is developing imaging diagnostics that complement its treatment approach, enhancing personalized treatment and patient outcomes [3] Upcoming Investor Conferences - The company will participate in the 36th Annual Piper Healthcare Conference on December 3, 2024, in New York, NY, with a fireside chat scheduled from 10:00 to 10:25 AM ET [2] - The company will also be present at the 7th Annual Evercore HealthCONx on December 5, 2024, in Coral Gables, FL, with a fireside chat from 10:50 to 11:10 AM ET [2] - Webcast events will be available live and archived for 90 days on the company's investor page [2] Clinical Development - The company's melanoma (VMT01) and neuroendocrine tumor (VMT-α-NET) programs are currently in Phase 1/2a imaging and therapy trials at leading academic institutions [4] - The company has developed a proprietary 212Pb generator to secure key isotopes for clinical trials and commercial operations [4]